Tacrolimus
- Product NDC
- 69238-2780
- 11-digit product format
- 692382780
- Labeler code
- 69238
- Product ID
- 69238-2780_05c70395-3037-4e8a-be20-dd9f4aebbe06
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tacrolimus
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Amneal Pharmaceuticals NY LLC
- Application
- ANDA215012
- Marketing category
- ANDA
- Marketing start
- 2026-03-02
- Substance
- TACROLIMUS
- Active strength
- .5 mg/1
- Pharmacologic classes
- Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A215012-001 | TACROLIMUS | TACROLIMUS | EQ 0.5MG BASE | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2024-01-25 | |
| A215012-002 | TACROLIMUS | TACROLIMUS | EQ 1MG BASE | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2024-01-25 | |
| A215012-003 | TACROLIMUS | TACROLIMUS | EQ 5MG BASE | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2024-01-25 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A215012-001 | AB |
| A215012-002 | AB |
| A215012-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A215012-001 | TACROLIMUS | EQ 0.5MG BASE | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2024-01-25 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A215012-002 | TACROLIMUS | EQ 1MG BASE | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2024-01-25 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A215012-003 | TACROLIMUS | EQ 5MG BASE | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2024-01-25 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A215012-001 | TACROLIMUS | EQ 0.5MG BASE | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2024-01-25 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A215012-002 | TACROLIMUS | EQ 1MG BASE | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2024-01-25 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A215012-003 | TACROLIMUS | EQ 5MG BASE | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2024-01-25 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A215012-001 | TACROLIMUS | EQ 0.5MG BASE | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2024-01-25 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A215012-002 | TACROLIMUS | EQ 1MG BASE | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2024-01-25 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A215012-003 | TACROLIMUS | EQ 5MG BASE | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2024-01-25 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A215012-001 | TACROLIMUS | EQ 0.5MG BASE | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2024-01-25 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A215012-002 | TACROLIMUS | EQ 1MG BASE | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2024-01-25 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A215012-003 | TACROLIMUS | EQ 5MG BASE | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2024-01-25 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A215012-001 | TACROLIMUS | EQ 0.5MG BASE | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2024-01-25 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A215012-002 | TACROLIMUS | EQ 1MG BASE | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2024-01-25 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A215012-003 | TACROLIMUS | EQ 5MG BASE | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2024-01-25 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A215012-001 | TACROLIMUS | EQ 0.5MG BASE | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2024-01-25 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A215012-002 | TACROLIMUS | EQ 1MG BASE | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2024-01-25 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A215012-003 | TACROLIMUS | EQ 5MG BASE | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2024-01-25 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A215012-001 | TACROLIMUS | EQ 0.5MG BASE | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2024-01-25 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A215012-002 | TACROLIMUS | EQ 1MG BASE | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2024-01-25 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A215012-003 | TACROLIMUS | EQ 5MG BASE | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2024-01-25 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A215012-001 | TACROLIMUS | EQ 0.5MG BASE | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2024-01-25 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A215012-002 | TACROLIMUS | EQ 1MG BASE | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2024-01-25 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A215012-003 | TACROLIMUS | EQ 5MG BASE | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2024-01-25 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A215012-001 | TACROLIMUS | EQ 0.5MG BASE | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2024-01-25 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A215012-002 | TACROLIMUS | EQ 1MG BASE | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2024-01-25 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A215012-003 | TACROLIMUS | EQ 5MG BASE | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2024-01-25 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A215012-001 | TACROLIMUS | EQ 0.5MG BASE | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2024-01-25 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A215012-002 | TACROLIMUS | EQ 1MG BASE | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2024-01-25 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A215012-003 | TACROLIMUS | EQ 5MG BASE | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2024-01-25 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A215012-001 | TACROLIMUS | EQ 0.5MG BASE | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2024-01-25 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A215012-002 | TACROLIMUS | EQ 1MG BASE | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2024-01-25 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A215012-003 | TACROLIMUS | EQ 5MG BASE | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2024-01-25 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A215012-001 | TACROLIMUS | EQ 0.5MG BASE | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2024-01-25 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A215012-002 | TACROLIMUS | EQ 1MG BASE | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2024-01-25 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A215012-003 | TACROLIMUS | EQ 5MG BASE | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2024-01-25 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A215012-001 | TACROLIMUS | EQ 0.5MG BASE | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2024-01-25 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A215012-002 | TACROLIMUS | EQ 1MG BASE | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2024-01-25 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A215012-003 | TACROLIMUS | EQ 5MG BASE | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2024-01-25 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A215012-001 | TACROLIMUS | EQ 0.5MG BASE | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2024-01-25 | 301d65b070ca… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A215012-001 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A215012-002 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A215012-003 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A215012-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A215012-002 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A215012-003 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A215012-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A215012-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A215012-003 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A215012-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A215012-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A215012-003 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A215012-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A215012-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A215012-003 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A215012-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A215012-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A215012-003 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A215012-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A215012-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A215012-003 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A215012-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A215012-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A215012-003 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A215012-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A215012-002 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A215012-003 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A215012-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A215012-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A215012-003 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A215012-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A215012-002 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A215012-003 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A215012-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A215012-002 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A215012-003 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A215012-001 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A215012-002 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A215012-003 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A215012-001 | AB | 1 | 301d65b070ca… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Tacrolimus
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| TACROLIMUS | .5 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| WM0HAQ4WNM | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 4eb1b6bd-beec-4dd5-9a48-c93a9fe918b3 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| df369ad4-19d8-393a-de46-8c6255b8b360 | Product name | 8 | 20251120 |
| d2a74186-7b26-dbcc-9435-50b3d0be14ab | Product name | 2 | 20250114 |
| a64835ae-fa9d-41d8-9a93-36828ba72b96 | Product name | 3 | 20190611 |
| b4a869e4-9fcd-47bd-95e3-85e7c75f8bad | Product name | 1 | 20150819 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69238-2780-3 | Tacrolimus | 3 in 1 BAG | CAPSULE, EXTENDED RELEASE | 3 | 1 | |
| 69238-2780-3 | Tacrolimus | 1 in 1 CARTON | CAPSULE, EXTENDED RELEASE | 1 | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Tacrolimus | TACROLIMUS | Amneal Pharmaceuticals NY LLC | 4eb1b6bd-beec-4dd5-9a48-c93a9fe918b3 | 2025-10-20 | Boxed warning, Warnings, Adverse reactions | 215012 ANDA215012 69238-2780 |
| tacrolimus | TACROLIMUS EXTENDED-RELEASE CAPSULES | Chengdu Suncadia Medicine Co., Ltd. | 08cf2861-2483-405d-a872-a88a5c235f9a | 2024-02-07 | Boxed warning, Warnings, Adverse reactions | 215012 ANDA215012 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1431971 | tacrolimus 0.5 MG 24HR Extended Release Oral Capsule | PSN | 4eb1b6bd-beec-4dd5-9a48-c93a9fe918b3 | 1 |
| 1431980 | tacrolimus 1 MG 24HR Extended Release Oral Capsule | PSN | 4eb1b6bd-beec-4dd5-9a48-c93a9fe918b3 | 1 |
| 1431985 | tacrolimus 5 MG 24HR Extended Release Oral Capsule | PSN | 4eb1b6bd-beec-4dd5-9a48-c93a9fe918b3 | 1 |
| 1431971 | 24 HR tacrolimus 0.5 MG Extended Release Oral Capsule | SCD | 4eb1b6bd-beec-4dd5-9a48-c93a9fe918b3 | 1 |
| 1431980 | 24 HR tacrolimus 1 MG Extended Release Oral Capsule | SCD | 4eb1b6bd-beec-4dd5-9a48-c93a9fe918b3 | 1 |
| 1431985 | 24 HR tacrolimus 5 MG Extended Release Oral Capsule | SCD | 4eb1b6bd-beec-4dd5-9a48-c93a9fe918b3 | 1 |
| 1431971 | tacrolimus 0.5 MG (as anhydrous tacrolimus) 24 HR Extended Release Oral Capsule | SY | 4eb1b6bd-beec-4dd5-9a48-c93a9fe918b3 | 1 |
| 1431980 | tacrolimus 1 MG (as anhydrous tacrolimus) 24 HR Extended Release Oral Capsule | SY | 4eb1b6bd-beec-4dd5-9a48-c93a9fe918b3 | 1 |
| 1431985 | tacrolimus 5 MG (as anhydrous tacrolimus) 24 HR Extended Release Oral Capsule | SY | 4eb1b6bd-beec-4dd5-9a48-c93a9fe918b3 | 1 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 69238-2780-3 | 69238278003 | 1 BAG in 1 CARTON (69238-2780-3) / 3 BLISTER PACK in 1 BAG / 10 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK | 1 bag | 2026-03-02 | No | No | Current |